Capricor Therapeutics | CAPR - Operating Expenses


Capricor Therapeutics reported $29.16M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Bioline Rx USD 2.63M 24K Sep/2025
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Cytokinetics USD 196.12M 27.43M Dec/2025
Geron USD 58.8M 2.31M Dec/2025
Grifols EUR 1.99B 217.4M Dec/2025
Immunic USD 23.33M 2.67M Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Prothena USD 27.23M 14.95M Dec/2025
PTC Therapeutics USD 246.3M 38.78M Dec/2025
Sarepta Therapeutics USD 853.02M 390.78M Dec/2025